Her primary areas of study are Notch signaling pathway, Immunology, Cell biology, Programmed cell death and Signal transduction. Her Notch signaling pathway research incorporates themes from Cancer, Stem cell and Cell fate determination. Her work deals with themes such as Receptor, Neuroscience, Outbreak and Pneumonia, which intersect with Immunology.
Her Cell biology study incorporates themes from T cell, T-cell receptor and Transcription factor. Her Programmed cell death research is within the category of Apoptosis. Her work carried out in the field of Apoptosis brings together such families of science as Thymocyte and DNA damage.
Cell biology, Notch signaling pathway, Immunology, Molecular biology and Apoptosis are her primary areas of study. Her research in Cell biology intersects with topics in Cell culture, Cellular differentiation and T cell, Immune system, T-cell receptor. Her Notch signaling pathway study combines topics from a wide range of disciplines, such as Cancer research and Protein kinase B.
Her Immunology research is multidisciplinary, relying on both Haematopoiesis and Stem cell. She studies Programmed cell death which is a part of Apoptosis. Her Programmed cell death study combines topics in areas such as Thymocyte and Gene.
Her primary areas of study are Cancer research, Cell biology, Notch signaling pathway, Triple-negative breast cancer and Immunotherapy. The Cancer research study combines topics in areas such as Mesenchymal stem cell, Cancer, Cancer stem cell and Hematopoietic stem cell transplantation. Barbara A. Osborne interconnects T cell, Cell culture, Cellular differentiation and FOXP3 in the investigation of issues within Cell biology.
Her Notch signaling pathway research integrates issues from Cell, Protein kinase B, Regulatory macrophages, Cytokine and NF-κB. Antibody is the subject of her research, which falls under Immunology. Her biological study spans a wide range of topics, including Carcinogenesis, Apoptosis, Targeted therapy and Proteasome.
Barbara A. Osborne mostly deals with Cell biology, Cancer research, Immune system, Notch signaling pathway and Antibody. The study incorporates disciplines such as Receptor, Cellular differentiation and T-cell receptor in addition to Cell biology. Her Immune system research includes themes of Cell culture, Psychological repression, In vitro and Cytokine.
Her study in Notch signaling pathway is interdisciplinary in nature, drawing from both Tumor microenvironment, Cancer stem cell, NF-κB, Transcription and Cancer immunology. Antibody is a subfield of Immunology that Barbara A. Osborne studies. Her work on Superantigen is typically connected to Arginase as part of general Immunology study, connecting several disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
p53 is required for radiation-induced apoptosis in mouse thymocytes
Scott W. Lowe;Earlene M. Schmitt;Sallie W. Smith;Barbara A. Osborne.
Nature (1993)
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation—A Prospective, Randomized, Double-Blind Study
M A Slavin;B Osborne;R Adams;M J Levenstein.
The Journal of Infectious Diseases (1995)
Do all programmed cell deaths occur via apoptosis
Lawrence M. Schwartz;Sallie W. Smith;Margaret E. E. Jones;Barbara A. Osborne.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.
Sanne Weijzen;Paola Rizzo;Mike Braid;Radhika Vaishnav.
Nature Medicine (2002)
Apoptotic Signals Delivered Through the T-Cell Receptor of a T-Cell Hybrid Require the Immediate-Early Gene Nur77
Zheng-Gang Liu;Sallie W. Smith;Kelly A. McLaughlin;Lawrence M. Schwartz.
Nature (1994)
Programmed cell death, apoptosis and killer genes
Lawrence M. Schwartz;Barbara A. Osborne.
Immunology Today (1993)
Targeting Notch to target cancer stem cells.
Antonio Pannuti;Kimberly Foreman;Paola Rizzo;Clodia Osipo.
Clinical Cancer Research (2010)
An Outbreak of Respiratory Syncytial Virus in a Bone Marrow Transplant Center
Robert D. Harrington;Thomas M. Hooton;Thomas M. Hooton;Robert C. Hackman;Robert C. Hackman;Gregory A. Storch;Gregory A. Storch.
The Journal of Infectious Diseases (1992)
Rational targeting of Notch signaling in cancer.
P Rizzo;C Osipo;K Foreman;T Golde.
Oncogene (2008)
Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents
Brian J Nickoloff;Barbara A Osborne;Lucio Miele.
Oncogene (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Florida
Louisiana State University Health Sciences Center New Orleans
Ikerbasque
University of Massachusetts Amherst
University of Massachusetts Amherst
Moffitt Cancer Center
Stanford University
AstraZeneca (United Kingdom)
Columbia University
Eli Lilly (United States)
University of Valencia
California Institute of Technology
University of Tokyo
University of Bologna
Tsinghua University
Tokyo Institute of Technology
University of Queensland
Eternal University
Zhejiang University
Rockefeller University
Universidade de São Paulo
University of Johannesburg
Monash University
Walter and Eliza Hall Institute of Medical Research
University of Michigan–Ann Arbor
Texas A&M University